Spark Therapeutics announced the launch of an unwritten public offering of 3 million shares of its common stock, according to a press release. Spark will offer 2 million shares and The Children’s Hospital of Philadelphia (CHOP) Foundation will offer 1 million shares in this public offering.
Data from the IRIS Registry has determined the rate of endophthalmitis after cataract surgery to be lower than reported rates from other US data sets. Medscape Ophthalmology
FLORENCE, Italy — In well-selected cases, vitrectomy might be a good and cost-effective alternative to pharmacotherapy for the treatment of diabetic macular edema, according to one specialist. At the FLOREtina meeting, J. Fernando Arevalo, MD, said that there is a rationale for vitrectomy because surgery removes traction, eliminates vasoproliferative factors, improves oxygenation and consequently reduces edema. However, the use of vitrectomy in DME is not supported by good clinical evidence.
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Avegant today announced the availability of its flagship product, the Glyph, designed with lightweight portability, rich audio and incredibly precise video.
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced Julian C. Baker has joined its Board of Directors. “After more than 20 years as a professional investor, Julian has extensive experience in financing and building companies in the life sciences industry,” said Leslie L. Iversen, Ph.D., Chairm
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …